US2023226001A1PendingUtilityA1

Non-crystallizing cannabidiol blends

65
Assignee: CHEMTOR LPPriority: Jan 27, 2020Filed: Mar 24, 2023Published: Jul 20, 2023
Est. expiryJan 27, 2040(~13.5 yrs left)· nominal 20-yr term from priority
A61K 31/658A61K 31/192A61K 31/05A61K 9/0031A61K 9/006A61K 9/0078A61K 9/0053A61K 9/007A61K 9/14A61P 25/04A61P 25/22
65
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A non-crystallizing blend includes cannabidiol (CBD) and cannabidiolic acid (CBDA). A method of forming a non-crystallizing blend of CBD and CBDA includes obtaining a CBD isolate including at least 80% by weight CBD, obtaining a CBDA isolate including at least 80% by weight CBDA, and combining and mixing the CBD isolate and the CBDA. A method of treating a condition includes administering a therapeutically effective amount of a non-crystallizing blend of CBD and CBDA to a patient in need thereof.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A cartridge for a vaporizing device comprising:
 a sealable container; and   a vaporizable, liquid blend contained within the container;   wherein the blend comprises cannabidiol (CBD) and cannabidiolic acid (CBDA) and inevitable impurities; and   wherein the blend does not form crystals measuring greater than 100 microns for at least 24 hours at 25° C.   
     
     
         2 . The cartridge according to  claim 1 , wherein the CBD is present in an amount of 50% by weight to 95% by weight, based on a total weight of the blend. 
     
     
         3 . The cartridge according to  claim 2 , wherein the CBDA is present in an amount of 5% by weight to 40% by weight, based on a total weight of the blend. 
     
     
         4 . The cartridge according to  claim 1 , wherein the blend consists of the CBD and the CBDA and less than 0.1 wt % impurities. 
     
     
         5 . The cartridge according to  claim 1 , wherein the CBD and CBDA account for at least 65% by weight, based on a total weight of the blend. 
     
     
         6 . The cartridge according to  claim 5 , wherein, based on a total weight of the blend, the CBD accounts for at least 50% by weight and the CBDA accounts for at least 5% by weight. 
     
     
         7 . The cartridge according to  claim 1 , wherein the blend does not crystallize within a temperature range of 0° C. to 50° C. 
     
     
         8 . The cartridge according to  claim 1 , wherein the container is sealed. 
     
     
         9 . The cartridge according to  claim 8 , wherein the container is sealed under pressure. 
     
     
         10 . A vaporizer comprising the cartridge of  claim 1 . 
     
     
         11 . A method comprising:
 providing a blend comprising cannabidiol (CBD) and cannabidiolic acid (CBDA) and inevitable impurities, wherein the blend does not form crystals measuring greater than 100 microns for at least 24 hours at 25° C.; and   heating the blend to a temperature sufficient to decarboxylate at least a portion of the CBDA into CBD;   wherein, after heating, the blend comprises a higher concentration of CBD and a lower concentration of CBDA as compared to before heating.   
     
     
         12 . The method of  claim 11 , further comprising ingesting the blend after heating. 
     
     
         13 . The method of  claim 11 , wherein heating comprises vaporizing the blend and the method further comprises inhaling the vaporized blend. 
     
     
         14 . The method of  claim 11 , wherein heating completely decarboxylates the CBDA. 
     
     
         15 . The method of  claim 11 , wherein the blend consists of the CBD and the CBDA and less than 0.1 wt % impurities. 
     
     
         16 . The method of  claim 15 , wherein the blend consists of 60 wt % to 95 wt % CBD and 5 wt % to 40 wt % CBDA. 
     
     
         17 . The method of  claim 16 , wherein heating comprises vaporizing the blend and the vaporized blend consists of 94.68 wt % to 99.435 wt % CBD and a balance of CO 2 .

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.